Showing results (3171-3180 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|November 5, 2018
Discrete Choice Experiments in Health Economics: Past, Present and FutureVikas Soekhai, Esther W de Bekker-Grob, Alan R Ellis, et al.Pharmacoeconomics|April 23, 2017
Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the LiteratureMaarten J IJzerman, Hendrik Koffijberg, Elisabeth Fenwick, et al.Pharmacoeconomics|April 6, 2019
The Economic Burden of Cystic Fibrosis in Germany from a Payer PerspectiveSimon Frey, Tom Stargardt, Udo Schneider, et al.Pharmacoeconomics|March 20, 2017
Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalNigel Fleeman, Adrian Bagust, Angela Boland, et al.Pharmacoeconomics|March 16, 2021
Real-World Treatment Costs and Care Utilization in Patients with Major Depressive Disorder With and Without Psychiatric Comorbidities in Specialist Mental HealthcareKaying Kan, Joran Lokkerbol, Frederike Jörg, et al.Pharmacoeconomics|March 22, 2021
Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction SuccessBjörn Schwander, Mark Nuijten, Silvia Evers, et al.Pharmacoeconomics|October 27, 2012
Cost effectiveness of therapeutic interventions in ankylosing spondylitis: a critical and systematic reviewCécile Gaujoux-Viala, Bruno FautrelPharmacoeconomics|January 28, 2014
Differential time preferences for money and quality of lifeM B Y Parouty, H H Le, D Krooshof, et al.Pharmacoeconomics|January 22, 2014
Eliciting preferences to inform patient-centred policies: the case of psoriasisAleksandra Torbica, Giovanni Fattore, Fabio AyalaPharmacoeconomics|May 28, 2014
HTA agencies facing model biases: the case of type 2 diabetesVéronique Raimond, Jean-Michel Josselin, Lise RochaixPageof 336